BioCentury | Nov 14, 2011
Company News

Prognomix, Servier deal

...targets to treat Type II diabetes. The companies will use Prognomix's genomic and bioinformatics technologies. Prognomix...
...payment while Servier will have the option to license resulting IP. Details were not disclosed. Prognomix Inc....
BioCentury | Oct 31, 2011
Company News

Prognomix management update

Prognomix Inc. , Montreal, Quebec Business: Diagnostic, Pharmacogenetics Hired: Normand Balthazard as CEO, formerly president of BioCapital Venture Capital Funds, which was acquired WIR Staff Diagnostic...
Items per page:
1 - 2 of 2
BioCentury | Nov 14, 2011
Company News

Prognomix, Servier deal

...targets to treat Type II diabetes. The companies will use Prognomix's genomic and bioinformatics technologies. Prognomix...
...payment while Servier will have the option to license resulting IP. Details were not disclosed. Prognomix Inc....
BioCentury | Oct 31, 2011
Company News

Prognomix management update

Prognomix Inc. , Montreal, Quebec Business: Diagnostic, Pharmacogenetics Hired: Normand Balthazard as CEO, formerly president of BioCapital Venture Capital Funds, which was acquired WIR Staff Diagnostic...
Items per page:
1 - 2 of 2